New York, New York—The Neuropsychoanalysis Association (NPSA) is hosting a conference for researchers and clinicians on depression, "Towards a Real Understanding of Depression: Lessons from the Treatment Battlefeld and New Research," on Friday, November 1, 2013 from 9:00 am to 6:00 pm at the Icahn School of Medicine at Mount Sinai, The Bonnie and Kenneth Davis Auditorium, 1470 Madison Avenue (between 101st and 102nd Streets) in New York City. Recent meta-analyses have indicated that SSRIs, although extremely effective for some, have not fulfilled their original promise of being a broadly successful anti-depressant. This full day program will be an interdisciplinary event focusing on pioneering work in biological psychiatry, basic neuroscience and other fields aimed at discovering new treatments for depression, including what have we learned so far, future directions; and how to use the data from new treatment research to hone in on the core pathophysiology of depression and models of brain organization which underlie approaches to treatment.
Featured keynote speakers include Steven Paul (Cornell), "Why we need new and better antidepressants: lessons from the treatment and clinical research battlefield;" and Jaak Panksepp (Washington State University), "Pre-clinical affective neuroscience modelling of depression, and evaluation of three new antidepressant strategies."
WHAT: Towards a Real Understanding of Depression: Lessons from the Treatment Battlefield and New Research
WHEN: Friday, November 1, 2013
9:00 am – 6:00 pm
WHERE: Icahn School of Medicine at Mount Sinai, Bonnie and Kenneth Davis Auditorium
1470 Madison Avenue (between 101st and 102nd Streets), NYC
REGISTRATION: Addavail Coslett, Associate Dir. Programming & Development email@example.com or 212-572-3693
Maggie Zellner, The Neuropsychoanalysis Foundation
Ronald Duman (Yale), Neurobiology of stress, depression and antidepressants: Remodeling synaptic connections
James Murrough (Mt Sinai), Ketamine as a fast-acting antidepressant
Elizabeth Fitelson (Columbia), Estrogen and other hormones in depression
Dan Javitt, (Columbia), Depression from a glutamatergic perspective: the interaction of neuromodulation and brain glutamatergic systems
Wayne Goodman (Mt. Sinai), DBS treatment for depression
Dan Iosifescu (Mt. Sinai School of Medicine), Non-invasive neurostimulation for the treatment of major depression
Cori Bargmann (Rockefeller), The BRAIN Initiative: Understanding brain circuits as a foundation for accelerating human neuroscience
Baruch Fishman (New York-Presbyterian/Weill Cornell), CBT perspectives on depression and treatment
Mark Solms (University of Cape Town), Psychoanalytic perspectives on depression and the panic-shutdown hypothesis
Andrew Gerber (Columbia), Empirical outcome studies of psychodynamic and cognitive behavioral therapies, and brain effects of treatment
The Neuropsychoanalysis Association (NPSA)
Bringing the brain and mind sciences together, the Neuropsychoanalysis Association has been working to bridge the gap between neuroscience and the psychotherapeutic approaches to mental health for over two decades. Fostering discussion, funding new research and making crucial scientific and theoretical connections, this interdisciplinary alliance plays an essential role in advancing our understanding of the human psyche. For more information visit http://www.npsafoundation.org/
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.